InterVest

Activity from announced rounds

Activity in this selectionSeries B
Rounds participated in
3
Confirmed lead rounds
—
3 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$130M
3 disclosed · full round size, not this investor’s share

By stage

Series B3

By primary sector

Biotech2
Healthtech1

By country

Netherlands1
South Korea1
United States1

Rounds

3 in this selection
Inocras

Whole-genome sequencing and bioinformatics platform for precision oncology

$31MSeries B
Role not disclosed
Vitestro

Develops autonomous robotic phlebotomy devices for diagnostic blood collection

$70MSeries B
Role not disclosed
Galux

Develops AI-driven protein design platform for de novo antibody and drug discovery

$29MSeries B
Role not disclosed